ENTRY       D00423                      Drug
NAME        Ribavirin (JP18/USP/INN);
            Copegus (TN);
            Rebetol (TN);
            Ribasphere (TN);
            Virazole (TN)
  ABBR      RBV
PRODUCT     RIBAVIRIN (Bryant Ranch Prepack)
            RIBAVIRIN (Cameron Pharmaceuticals)
            RIBAVIRIN (Oceanside Pharmaceuticals)
            RIBAVIRIN (Pharma Packaging Solutions)
            VIRAZOLE (Bausch Health US)
  GENERIC   RIBAVIRIN (Aurobindo Pharma Limited)
            RIBAVIRIN (Aurobindo Pharma Limited)
            RIBAVIRIN (Navinta LLC)
            RIBAVIRIN (Zydus Lifesciences Limited)
            RIBAVIRIN (Zydus Lifesciences Limited)
            RIBAVIRIN (Zydus Pharmaceuticals USA)
            RIBAVIRIN (Zydus Pharmaceuticals USA)
            RIBAVIRIN (Zydus Pharmaceuticals USA)
FORMULA     C8H12N4O5
EXACT_MASS  244.0808
MOL_WEIGHT  244.2047
CLASS       Antiviral
             DG01440  Arabinofuranosyl type antiviral
             DG03198  Anti-HCV agent
              DG02000  HCV NS5B polymerase inhibitor
REMARK      Therapeutic category: 6250
            ATC code: J05AP01
            Product: D00423<JP/US>
EFFICACY    Antiviral
  DISEASE   Chronic hepatitis C [DS:H00413]
            RSV infection [DS:H00401]
COMMENT     In combination with peginterferon alfa-2a
TARGET      HCV NS5B polymerase [KO:K22472]
  PATHWAY   ko03230(K22472)  Viral genome structure
            ko03240(K22472)  Viral replication
            ko05160(K22472)  Hepatitis C
INTERACTION  
STR_MAP     map07044  Antiviral agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AP Antivirals for treatment of HCV infections
                 J05AP01 Ribavirin
                  D00423  Ribavirin (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-hepatitis C (HCV) Agents
               Ribavirin
                D00423  Ribavirin (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D00423  Ribavirin (JP18/USP/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG01440  Arabinofuranosyl type antiviral
               D00423  Ribavirin
              DG03198  Anti-HCV agent
               DG02000  HCV NS5B polymerase inhibitor
                D00423  Ribavirin
            Drug classes [BR:br08332]
             Antiviral
              DG03198  Anti-HCV agent
               D00423  Ribavirin
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HCV NS5A/NS5B inhibitor
                D00423  Ribavirin (JP18/USP/INN) &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HCV NS5A/NS5B inhibitor
                D00423  Ribavirin (JP17/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00423  Ribavirin
              D00423  Ribavirin capsules
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00423
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00423
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00423
DBLINKS     CAS: 36791-04-5
            PubChem: 7847489
            ChEBI: 63580
            PDB-CCD: RBV
            LigandBox: D00423
            NIKKAJI: J17.798I
ATOM        17
            1   N4y N    25.5905  -16.0641
            2   N5x N    26.7827  -16.9056
            3   C1y C    24.3282  -16.4848
            4   C8x C    26.0814  -14.7316
            5   C8y C    27.9047  -16.0641
            6   O2x O    23.1360  -15.6433
            7   C1y C    23.8373  -17.8173
            8   N5x N    27.4840  -14.7316
            9   C5a C    29.1670  -16.6251
            10  C1y C    22.0140  -16.4848
            11  C1y C    22.4347  -17.8173
            12  O1a O    24.6788  -18.9393
            13  N1a N    29.1673  -18.0277
            14  O5a O    30.2891  -15.8537
            15  C1b C    20.6815  -16.0641
            16  O1a O    21.6633  -18.9393
            17  O1a O    19.6297  -16.9757
BOND        18
            1     1   2 1
            2     3   1 1 #Up
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     5   9 1
            9     6  10 1
            10    7  11 1
            11    7  12 1 #Down
            12    9  13 1
            13    9  14 2
            14   10  15 1 #Up
            15   11  16 1 #Down
            16   15  17 1
            17    5   8 1
            18   10  11 1
///
